SCHEMBL2865743

SCHEMBL2865743

CCCCCCCCCCCCCC(=O)OC(C(=O)O)C(O)(CC(=O)O)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 3/20 0.55
HSPD1 P10809 1/20 0.55
HSPE1 P61604 1/20 0.55
LMNA P02545 6/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 1/20 0.47
RECQL P46063 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPK1 P28482 5/20 0.46
MAPT P10636 4/20 0.46
GMNN O75496 3/20 0.45
NPSR1 Q6W5P4 3/20 0.45
CYP1A2 P05177 3/20 0.45
HSP90AA1 P07900 2/20 0.45
NR1H4 Q96RI1 2/20 0.45
TP53 P04637 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863429 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2864585 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2870941 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2872960 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2869644 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2870981 1.00 BLM (0.55) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2864433 0.90 ALDH1A1 (0.53) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2864717 0.88 BLM (0.48) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2872010 0.88 BLM (0.48) BLMHSPD1HSPE1LMNAMEN1
SCHEMBL2868494 0.88 BLM (0.48) BLMHSPD1HSPE1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023074894-A1 CARTILAGE REGENERATION PROMOTER 小林製薬株式会社 2023-05-04 WO disclosed
US-20170312200-A1 AN AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION SHOWA DENKO K.K. (JP) 2017-11-02 US disclosed
EP-3213739-A1 AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION AND ANTI-AGING COMPOSITION Showa Denko K.K. (JP) 2017-09-06 EP disclosed
EP-1799631-B1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME SHOWA DENKO KK (JP) 2017-01-25 EP disclosed
US-7846970-B2 Hydroxycitric acid derivatives and skin external preparations containing the same SHOWA DENKO K.K. (JP) 2010-12-07 US disclosed
US-20070293577-A1 Hydroxycitric Acid Derivatives And Skin External Preparations Using The Same SHOWA DENKO K.K. (JP) 2007-12-20 US disclosed
EP-1799631-A1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME Showa Denko K.K. (JP) 2007-06-27 EP disclosed
WO-2006033476-A1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME SHOWA DENKO K.K. (JP) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312200-A1 AN AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION UQCRC1, ACAD9, CYP27B1 BLM 2978/4885HSPD1 75/4885HSPE1 54/4885
US-20070293577-A1 Hydroxycitric Acid Derivatives And Skin External Preparations Using The Same HAAO, CYP8B1, CUTA BLM 2887/4885HSPD1 271/4885HSPE1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.